Business Description
Evelo Biosciences Inc
NAICS : 325411
SIC : 2833
ISIN : US2997342025
Description
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.86 | |||||
9-Day RSI | 41.19 | |||||
14-Day RSI | 43.86 | |||||
6-1 Month Momentum % | -80 | |||||
12-1 Month Momentum % | -80 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:EVLO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Evelo Biosciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -14 | ||
| Beta | -2.4846 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.67 | ||
| Volatility % | 81.73 | ||
| 14-Day RSI | 43.86 | ||
| 14-Day ATR ($) | 0.000017 | ||
| 20-Day SMA ($) | 0.00013 | ||
| 12-1 Month Momentum % | -80 | ||
| 52-Week Range ($) | 0.0001 - 0.0006 | ||
| Shares Outstanding (Mil) | 18.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Evelo Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Evelo Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 139 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 54 days | ||
| Annual report for 2025 | 2026-07-01 | In 4 days | ||
| First quarter earnings results for 2026 | 2026-07-01 | In 4 days | ||
| General meeting for 2025 | 2026-06-30 | In 3 days | ||
| 0.05:1 Stock Split | 2023-06-30 | 3.53 (-7.45%) |
Show
Entries
Evelo Biosciences Inc Frequently Asked Questions
What is Evelo Biosciences Inc(EVLO)'s stock price today?
The current price of EVLO is $0.00. The 52 week high of EVLO is $0.00 and 52 week low is $0.00.
When is next earnings date of Evelo Biosciences Inc(EVLO)?
The next earnings date of Evelo Biosciences Inc(EVLO) is 2026-07-01 Est..
Does Evelo Biosciences Inc(EVLO) pay dividends? If so, how much?
Evelo Biosciences Inc(EVLO) does not pay dividend.
Guru Commentaries on OTCPK:EVLO
No articles.
Press Release
Articles on Evelo Biosciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers